Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Cell

• Publication date

  2016-01-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ccell.2015.12.006PMID 26766588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Context-dependent actions of Polycomb repressors in cancer

  2016cited by this paper
• Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.

  2015cited by this paper
• The emerging roles of YAP and TAZ in cancer

  2015cited by this paper
• Ezh2 represses the basal cell lineage during lung endoderm development

  2015cited by this paper
• Targeting molecular addictions in cancer

  2014cited by this paper
• KRAS and YAP1 converge to regulate EMT and tumor survival.

  2014cited by this paper
• Multiple cells-of-origin of mutant K-Ras–induced mouse lung adenocarcinoma

  2014influential reference
• Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner.

  2014cited by this paper
• Alveolar progenitor and stem cells in lung development, renewal and cancer

  2014cited by this paper
• EED regulates epithelial-mesenchymal transition of cancer cells induced by TGF-β.

  2014cited by this paper
• EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumors to TopoII inhibitors

  2014influential reference
• The polycomb group protein EZH2 inhibits lung cancer cell growth by repressing the transcription factor Nrf2

  2014cited by this paper
• Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer

  2014cited by this paper
• PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies

  2014cited by this paper
• Comprehensive molecular profiling of lung adenocarcinoma

  2014cited by this paper
• Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors

  2014cited by this paper
• Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.

  2014cited by this paper
• Snail recruits Ring1B to mediate transcriptional repression and cell migration in pancreatic cancer cells.

  2014cited by this paper
• A new world of Polycombs: unexpected partnerships and emerging functions

  2013cited by this paper
• Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.

  2013cited by this paper
• Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells.

  2013cited by this paper
• Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells.

  2013cited by this paper
• Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming.

  2013cited by this paper
• A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal.

  2013influential reference
• A Histone Mutant Reproduces the Phenotype Caused by Loss of Histone-Modifying Factor Polycomb

  2013cited by this paper
• HNF4&agr; as a Marker for Invasive Mucinous Adenocarcinoma of the Lung

  2013cited by this paper
• Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2

  2013cited by this paper
• In vivo RNAi screen for BMI1 targets identifies TGF-β/BMP-ER stress pathways as key regulators of neural- and malignant glioma-stem cell homeostasis.

  2013influential reference
• EZH2 couples pancreatic regeneration to neoplastic progression.

  2012cited by this paper
• Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

  2012cited by this paper
• A complex Polycomb issue: the two faces of EZH2 in cancer.

  2012cited by this paper
• EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

  2012influential reference
• KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.

  2012cited by this paper
• Lung stem cell self-renewal relies on BMI1-dependent control of expression at imprinted loci.

  2011cited by this paper
• NuRD-mediated deacetylation of H3K27 facilitates recruitment of Polycomb Repressive Complex 2 to direct gene repression

  2011cited by this paper
• Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.

  2011cited by this paper
• The Polycomb complex PRC2 and its mark in life

  2011cited by this paper
• Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker

  2011cited by this paper
• Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells.

  2010cited by this paper
• Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes

  2010cited by this paper
• Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

  2010cited by this paper
• The sterile inflammatory response.

  2010cited by this paper
• The essence of senescence.

  2010influential reference
• Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition

  2010cited by this paper
• Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models

  2010cited by this paper
• Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

  2009cited by this paper
• NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation.

  2009cited by this paper
• Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

  2009influential reference
• Inflammation and EMT: an alliance towards organ fibrosis and cancer progression

  2009influential reference
• CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing

  2009cited by this paper
• The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2.

  2009cited by this paper
• An elaborate pathway required for Ras-mediated epigenetic silencing

  2007cited by this paper
• Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis

  2007cited by this paper
• Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.

  2007cited by this paper
• The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells.

  2007influential reference
• The Polycomb Group Protein Suz12 Is Required for Embryonic Stem Cell Differentiation

  2007cited by this paper
• Polycomb group protein ezh2 controls actin polymerization and cell signaling.

  2005cited by this paper
• The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation.

  2005cited by this paper
• Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

  2001cited by this paper
• Somatic activation of the K-ras oncogene causes early onset lung cancer in mice

  2001cited by this paper
• The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

  1999influential reference

• Dual Effect of EZH2 Gene Editing with CRISPR/Cas9 in Lung Cancer

  2026cites this paper
• PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibition.

  2026cites this paper
• Mechanistic evaluation of hyperoside against non-small cell lung cancer: a combined approach of network pharmacology and in vitro experimental validation

  2025cites this paper
• EED Maintains the Small Cell Lung Cancer Neuroendocrine Phenotype and Drives Lung Cancer Histological Transformation

  2025cites this paper
• Epithelial-mesenchymal transition.

  2025cites this paper
• Polycomb repressive complex 2 (PRC2) pathway’s role in cancer cell plasticity and drug resistance

  2025influential citation
• Regulation of histone H3K27 methylation in inflammation and cancer

  2025cites this paper
• Evolutionary fingerprints of epithelial-to-mesenchymal transition

  2025cites this paper
• Epigenetic regulation of cancer stemness

  2025cites this paper
• Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer

  2024cites this paper
• A STAG2-PAXIP1/PAGR1 axis suppresses lung tumorigenesis

  2024cites this paper
• A STAG2-PAXIP1/PAGR1 axis suppresses lung tumorigenesis

  2024cites this paper
• Cracking the Codes behind Cancer Cells’ Immune Evasion

  2024cites this paper
• Potential Therapeutic Targets in Myeloid Cell Therapy for Overcoming Chemoresistance and Immune Suppression in Gastrointestinal Tumors.

  2024cites this paper
• Cell States in Cancer: Drivers, Passengers, and Trailers.

  2024cites this paper
• Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial-Mesenchymal Transition.

  2024cites this paper
• SETD2 regulates chromatin accessibility and transcription to suppress lung tumorigenesis

  2023cites this paper
• Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors

  2023cites this paper
• EZH2 represses mesenchymal genes and upholds the epithelial state of breast carcinoma cells

  2023cites this paper
• Exploring the therapeutic potential of targeting polycomb repressive complex 2 in lung cancer

  2023cites this paper
• EZH2 and matrix co-regulate phenotype and KCNB2 expression in bladder smooth muscle cells.

  2023cites this paper
• Tcf21 Alleviates Pancreatic Fibrosis by Regulating the Epithelial-Mesenchymal Transformation of Pancreatic Stellate Cells

  2023cites this paper
• EZH2 represses mesenchymal genes and upholds epithelial identity in breast cancer cells

  2023cites this paper
• Mechanisms driving the immunoregulatory function of cancer cells

  2023cites this paper
• Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis

  2022cites this paper
• PRC2 loss drives MPNST metastasis and matrix remodeling

  2022cites this paper
• Dysregulated Polycomb Repressive Complex 2 contributes to chronic obstructive pulmonary disease by rewiring stem cell fate

  2022cites this paper
• EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies

  2022cites this paper
• Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor

  2022cites this paper
• Polycomb Directed Cell Fate Decisions in Development and Cancer

  2022cites this paper
• Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer

  2022cites this paper
• TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer

  2022cites this paper
• Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer.

  2022cites this paper
• EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization

  2022cites this paper
• Mitochondrial shape alteration by metabolites

  2022cites this paper
• RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia

  2022cites this paper
• EZH2 endorses cell plasticity to carcinoma cells facilitating mesenchymal to epithelial transition and tumour colonization

  2022cites this paper
• Nanog maintains stemness of Lkb1‐deficient lung adenocarcinoma and prevents gastric differentiation

  2021cites this paper
• EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition.

  2021cites this paper
• The histone methyltransferase Ezh2 restrains macrophage inflammatory responses

  2021cites this paper
• Polycomb-group proteins in the initiation and progression of cancer.

  2021cites this paper
• HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness

  2021cites this paper
• Proteomic Analysis Reveals That Placenta-Specific Protein 9 Inhibits Proliferation and Stimulates Motility of Human Bronchial Epithelial Cells

  2021cites this paper
• Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications

  2021cites this paper
• Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments

  2021cites this paper
• Functional antagonism of chromatin modulators regulates epithelial-mesenchymal transition

  2021cites this paper
• Potential of enhancer of zeste homolog 2 inhibitors for the treatment of SWI/SNF mutant cancers and tumor microenvironment modulation

  2021cites this paper
• Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma.

  2020cites this paper
• Targeting Epigenetics in Lung Cancer.

  2020cites this paper
• Regulating Methylation at H3K27: A Trick or Treat for Cancer Cell Plasticity

  2020cites this paper
• HNRNPM controls circRNA biogenesis and splicing fidelity to sustain prostate cancer cell fitness

  2020cites this paper
• Phenotypic mapping of pathological crosstalk between glioblastoma and innate immune cells by synthetic genetic tracing.

  2020influential citation
• YRDC is upregulated in non-small cell lung cancer and promotes cell proliferation by decreasing cell apoptosis

  2020cites this paper
• USP15 Deubiquitinase Safeguards Hematopoiesis and Genome Integrity in Hematopoietic Stem Cells and Leukemia Cells

  2020cites this paper
• Proteomic analysis reveals that Placenta-speci c 9 induces cell proliferation and motility programs in human bronchial epithelial cells

  2020cites this paper
• The Role of Polycomb Repressive Complex in Malignant Peripheral Nerve Sheath Tumor

  2020cites this paper
• Drugging histone methyltransferases in cancer.

  2020cites this paper
• Ezh2 restrains macrophage inflammatory responses, and is critical for neutrophil migration in response to pulmonary infection

  2020cites this paper
• ONECUT2 overexpression promotes RAS-driven lung adenocarcinoma progression

  2019cites this paper
• Histone deacetylase 7 inhibits plakoglobin expression to promote lung cancer cell growth and metastasis.

  2019cites this paper
• Lamin B1 loss promotes lung cancer development and metastasis by epigenetic derepression of RET

  2019cites this paper
• The JAK/STAT Pathway in Skeletal Muscle Pathophysiology

  2019cites this paper
• HOXB13 networking with ABCG1/EZH2/Slug mediates metastasis and confers resistance to cisplatin in lung adenocarcinoma patients

  2019cites this paper
• Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia.

  2019cites this paper
• Self-circulating electrochemiluminescence chip for sensitive detection of circulating tumour nucleic acids in blood

  2019cites this paper
• Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities

  2018influential citation
• In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis

  2018cites this paper
• LncRNAs: Proverbial Genomic “Junk” or Key Epigenetic Regulators During Cardiac Fibrosis in Diabetes?

  2018cites this paper
• Transcriptional deregulation underlying the pathogenesis of small cell lung cancer.

  2018influential citation
• Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages

  2018cites this paper
• hPCL3s Promotes Hepatocellular Carcinoma Metastasis by Activating β-Catenin Signaling.

  2018cites this paper
• Long intergenic non-protein coding RNA 319 aggravates lung adenocarcinoma carcinogenesis by modulating miR-450b-5p/EZH2.

  2018cites this paper
• Next-Generation in vivo Modeling of Human Cancers

  2018cites this paper
• Epigenetically distinct sister chromatids and asymmetric generation of tumor initiating cells

  2018cites this paper
• LncRNA LINC00968 accelerates the proliferation and fibrosis of diabetic nephropathy by epigenetically repressing p21 via recruiting EZH2.

  2018cites this paper
• TUSC3 accelerates cancer growth and induces epithelial‐mesenchymal transition by upregulating claudin‐1 in non‐small‐cell lung cancer cells

  2018cites this paper
• Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells

  2018cites this paper
• Mechanisms of change in the gene expression landscape during development and cancer in Drosophila melanogaster

  2018cites this paper
• Epigenetic mechanisms regulating epithelial-mesenchymal plasticity in breast cancer

  2018cites this paper
• Co-targeting kinases and epigenetic regulators for the treatment of Ras-driven lung cancer

  2018cites this paper
• The lung microenvironment: an important regulator of tumour growth and metastasis

  2018cites this paper
• MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy

  2018cites this paper
• FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer

  2018cites this paper
• Heterochromatin Reduction Correlates with the Increase of the KDM4B and KDM6A Demethylases and the Expression of Pericentromeric DNA during the Acquisition of a Transformed Phenotype

  2017influential citation
• DIAPH3 promoted the growth, migration and metastasis of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling

  2017cites this paper
• Elevated Metabolic Activity on 18F-FDG PET/CT Is Associated with the Expression of EZH2 in Non-small Cell Lung Cancer.

  2017cites this paper
• Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment

  2017cites this paper
• Antiangiogenesis and gene aberration-related therapy may improve overall survival in patients with concurrent KRAS and TP53 hotspot mutant cancer

  2017cites this paper
• [The biological complexity of Polycomb group proteins: the case of EZH2].

  2017cites this paper
• Carnosol‐mediated Sirtuin 1 activation inhibits Enhancer of Zeste Homolog 2 to attenuate liver fibrosis

  2017cites this paper
• The pseudogene-derived long noncoding RNA SFTA1P is down-regulated and suppresses cell migration and invasion in lung adenocarcinoma

  2017cites this paper
• Lung carcinogenesis and fibrosis taken together: just coincidence?

  2017cites this paper
• Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma

  2017influential citation
• Au cœur d’une complexité biologique : EZH2, une protéine du groupe Polycomb

  2017cites this paper
• Awakening of "Schlafen11" to Tackle Chemotherapy Resistance in SCLC.

  2017cites this paper
• Identifying key regulating miRNAs in hepatocellular carcinomas by an omics’ method

  2017cites this paper
• STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway.

  2017cites this paper
• Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular States.

  2017cites this paper
• Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2

  2017cites this paper
• Epigenetics during EMT in lung cancer: EZH2 as a potential therapeutic target

  2017cites this paper